Percentile
|
Vol 18
|
N°6
|
2013
22
Références
1.
Watson h, Rashkind WJ. Creation of atrial septal defects by balloon catheter in babies with transposition
of the great arteries. Lancet 1967;1(7487):403-5.
2.
Kan Js, White Ri Jr, mitchell sE, gardner tJ. percutaneous balloon valvuloplasty: a new method for treating
congenital pulmonary-valve stenosis. n Engl J med 1982;307(9):540-2.
3. holzer RJ, gauvreau K, Kreutzer, et al. safety and efficacy of balloon pulmonary valvuloplasty: a multicen-
ter experience. Catheter Cardiovasc interv 2012;80(4):663-72.
4.
Lock JE, Castaneda-Zuniga WR, Fuhrman Bp, Bass JL. Balloon dilation angioplasty of hypoplastic and
stenotic pulmonary arteries. Circulation 1983;67(5):962-7.
5. trant CA Jr, o'Laughlin mp, ungerleider Rm, garson A Jr. Cost-effectiveness analysis of stents, balloon
angioplasty, and surgery for the treatment of branch pulmonary artery stenosis. pediatr Cardiol
1997;18(5):339-44.
6.
Lock JE, Bass JL, Amplatz K, Fuhrman Bp, Castaneda-Zuniga W. Balloon dilation angioplasty of aortic
coarctations in infants and children. Circulation 1983;68(1):109-16.
7.
Bentham J, shettihalli n, orchard E, Westaby s, Wilson n. Endovascular stent placement is an acceptable
alternative to reoperation in selected infants with residual or recurrent aortic arch obstruction. Catheter
Cardiovasc interv 2010;76(6):852-9.
8.
Forbes tJ, Kim DW, Du W, et al.; CCisC investigators. Comparison of surgical, stent, and balloon angioplasty
treatment of native coarctation of the aorta: an observational study by the CCisC (Congenital Cardiovascu-
lar interventional study Consortium). J Am Coll Cardiol 2011;58(25):2664-74.
9.
Butera g, manica JL, Chessa m, et al. Covered-stent implantation to treat aortic coarctation. Expert Rev
med Devices. 2012 mar;9(2):123-30. doi: 10.1586/erd.12.2. Review.
10. Krasemann t, Bano m, Rosenthal E, Qureshi sA. Results of stent implantation for native and recurrent
coarctation of the aorta-follow-up of up to 13 years. Catheter Cardiovasc interv 2011;78(3):405-12.
11. Lababidi Z, Wu JR, Walls Jt. percutaneous balloon aortic valvuloplasty: results in 23 patients. Am J Cardiol
1984;53(1):194-7.
12. Zain Z, Zadinello m, menahem s, Brizard C. neonatal isolated critical aortic valve stenosis: balloon valvu-
loplasty or surgical valvotomy. heart Lung Circ 2006;15(1):18-23.
13. Brown JW, Rodefeld mD, Ruzmetov m, Eltayeb o, Yurdakok o, turrentine mW. surgical valvuloplasty versus
balloon aortic dilation for congenital aortic stenosis: are evidence-based outcomes relevant? Ann thorac
surg 2012;94(1):146-53.
14. maskatia sA, Justino h, ing FF, Crystal mA, mattamal RJ, petit CJ. Aortic valve morphology is associated
with outcomes following balloon valvuloplasty for congenital aortic stenosis. Catheter Cardiovasc interv
2013;81(1):90-5.
15. giroud Jm, Jacobs Jp. Evolution of strategies for management of the patent arterial duct. Cardiol Young.
2007;17.
16. Bentham J, meur s, hudsmith L, Archer n, Wilson n. Echocardiographically guided catheter closure of
arterial ducts in small preterm infants on the neonatal intensive care unit. Catheter Cardiovasc interv
2011;77(3):409-15.
17. Kammache i, mancini J, ovaert C, habib g, Fraisse A. Feasibility of transcatheter closure in unselected
patients with secundum atrial septal defect, using Amplatzer devices and a modified sizing balloon
technique. Catheter Cardiovasc interv 2011;78(5):665-74.
18. Cardenas L, panzer J, Boshoff D, malekzadeh-milani s, ovaert C. transcatheter closure of secundum atrial
defect in small children. Catheter Cardiovasc interv 2007;69(3):447-52.
19. Butera g, Biondi-Zoccai g, sangiorgi g, et al. percutaneous versus surgical closure of secundum atrial
septal defects: a systematic review and meta-analysis of currently available clinical evidence. Eurointer-
vention 2011;7(3):377-85.
20. holzer R, Balzer D, Cao QL, Lock K, hijazi Zm; Amplatzer muscular Ventricular septal Defect investigators.
Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal
defect occluder: immediate and mid-term results of a u.s. registry. J Am Coll Cardiol 2004;43(7):1257-63.
21. paoli F, Dragulescu A, Amedro p, et al. [A monocenter experience of ventricular septal defects treated by
catherization]. Arch mal Coeur Vaiss 2007;100(5):380-5. French.
22. ovaert C, Dragulescu A, sluysmans t, Carminati m, Fraisse A. Early surgical removal of membra-
nous ventricular septal device might allow recovery of atrio-ventricular block. pediatr Cardiol
2008;29(5):971-5.
23. Bonhoeffer p, Boudjemline Y, saliba Z, et al. percutaneous replacement of pulmonary valve in a right-
ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet 2000;356(9239):1403-5.
24. Lurz p, Coats L, Khambadkone s, et al. percutaneous pulmonary valve implantation: impact of evolving
technology and learning curve on clinical outcome. Circulation 2008;117(15):1964-72.
25. Boudjemline Y, Brugada g, Van-Aerschot i, et al. outcomes and safety of transcatheter pulmonary
valve replacement in patients with large patched right ventricular outflow tracts. Arch Cardiovasc Dis
2012;105(8-9):404-13.
26. Boshoff DE, Cools BL, heying R, et al. off-label use of percutaneous pulmonary valved stents in the right
ventricular outflow tract: time to rewrite the label? Catheter Cardiovasc interv 2013;81(6):987-95.
27. Akintürk h, michel-Behnke i, Valeske K, et al. hybrid transcatheter-surgical palliation: basis for univentri-
cular or biventricular repair: the giessen experience. pediatr Cardiol 2007;28(2):79-87.
28. Fouilloux V, Bonello B, gran C, Fraisse A, macé L, Kreitmann B. perventricular closure of muscular ventri-
cular septal defects in infants with echocardiographic guidance only. World J pediatr Congenit heart surg
2012;3(4):446-51.
29. Agnoletti g, Bonnet C, Boudjemline Y, et al. Complications of paediatric interventional catheterisation: an
analysis of risk factors. Cardiol Young 2005;15(4):402-8.
QuE REtEniR ou «tAKE-homE mEssAgE»
·
Une nette amélioration des qualités techniques du matériel, des
sondes, des prothèses, etc. permettant de travailler dans de
meilleures conditions, avec moins de risques et avec de meilleurs
résultats. La diversification du matériel a également permis un
élargissement des indications en termes d'âge du patient et
d'anatomie de la lésion à traiter
·
Une meilleure gestion des complications des prises en charge
antérieures.
·
Une collaboration nettement améliorée entre chirurgien et
cathétériseur au profit du patient, afin de réduire la lourdeur
chirurgicale, d'en améliorer les résultats à court et long termes,
d'améliorer la qualité de vie du patient et de sa famille. Le
chirurgien «prépare» le terrain pour des gestes percutanés
ultérieurs. Le cathétériseur raccourcit et allège les gestes
chirurgicaux en proposant les techniques percutanées associées.
·
Une volonté de maintenir le progrès à tous les niveaux.
Retrouvez Percentile sur internet
www.percentile.be